Gary Ingenito, MD, PhD, has been named senior vice president, clinical development and regulatory affairs, for Angiotech Pharmaceuticals (Vancouver). He formerly was senior vice president of contract research organization SFBC International. Angiotech is focused on developing drug-eluting medical devices and biomaterials.